• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Effect of Primary Surgery on Quality of Life in De Novo Stage IV Breast Cancer Patients.

作者信息

Si Yiran, Yuan Peng

机构信息

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

Ann Surg Oncol. 2020 Apr;27(4):1034-1035. doi: 10.1245/s10434-019-08130-z. Epub 2020 Feb 7.

DOI:10.1245/s10434-019-08130-z
PMID:32034576
Abstract
摘要

相似文献

1
ASO Author Reflections: Effect of Primary Surgery on Quality of Life in De Novo Stage IV Breast Cancer Patients.ASO作者反思：初次手术对初诊IV期乳腺癌患者生活质量的影响
Ann Surg Oncol. 2020 Apr;27(4):1034-1035. doi: 10.1245/s10434-019-08130-z. Epub 2020 Feb 7.
2
Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.转移性模式可区分新诊断 IV 期乳腺癌行原发性手术的生存获益：一项真实世界观察性研究。
Eur J Surg Oncol. 2019 Aug;45(8):1364-1372. doi: 10.1016/j.ejso.2019.02.013. Epub 2019 Feb 19.
3
Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.曲妥珠单抗为基础的治疗用于 HER2 阳性初治或复发的 IV 期乳腺癌女性的临床结局。
Breast. 2014 Feb;23(1):44-9. doi: 10.1016/j.breast.2013.10.005. Epub 2013 Nov 7.
4
CAUSES OF DEATH IN PATIENTS WITH STAGE 0-II BREAST CANCER.0-II期乳腺癌患者的死亡原因
Rev Med Chir Soc Med Nat Iasi. 2015 Apr-Jun;119(2):374-8.
5
Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective.局部区域性治疗新诊断 IV 期乳腺癌患者的原发肿瘤：放射肿瘤学家的观点。
Clin Breast Cancer. 2018 Apr;18(2):e167-e178. doi: 10.1016/j.clbc.2017.06.002. Epub 2017 Jun 17.
6
ASO Author Reflections: Key Challenges in Expanding the Utilization of Nipple-Sparing Mastectomy.美国外科医师学会作者反思：扩大保留乳头乳房切除术应用的关键挑战
Ann Surg Oncol. 2020 Feb;27(2):373-374. doi: 10.1245/s10434-019-07989-2. Epub 2019 Oct 28.
7
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.IV期乳腺癌且原发肿瘤完整患者的原发肿瘤切除效果
Ann Surg Oncol. 2006 Jun;13(6):776-82. doi: 10.1245/ASO.2006.03.033. Epub 2006 Apr 17.
8
ASO Author Reflections: Risk of Locoregional Recurrence After Nipple-Sparing Mastectomy and Immediate Breast Reconstruction for Pure Ductal Carcinoma In Situ.
Ann Surg Oncol. 2020 May;27(5):1636-1637. doi: 10.1245/s10434-020-08289-w. Epub 2020 Feb 28.
9
Development and trends of surgical modalities for breast cancer in China: a review of 16-year data.中国乳腺癌手术方式的发展与趋势：16年数据回顾
Ann Surg Oncol. 2007 Sep;14(9):2502-9. doi: 10.1245/s10434-007-9436-2. Epub 2007 Jun 13.
10
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.接受一线曲妥珠单抗为基础治疗的新诊断 IV 期或复发性 HER2 阳性转移性乳腺癌患者的治疗模式和临床结局：一项多中心回顾性队列研究。
Clin Breast Cancer. 2017 Dec;17(8):601-610.e2. doi: 10.1016/j.clbc.2017.04.002. Epub 2017 Apr 11.